Estadísticas de Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study

Visitas totales

views
Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study 4

Visitas totales por mes

views
October 2025 0
November 2025 0
December 2025 0
January 2026 0
February 2026 0
March 2026 0
April 2026 4

Vistas principales por país

views
Colombia 4

Visitas principales por ciudad

views
Barranquilla 4